DPP4 and diabetic kidney disease: Moreover, in an experimental model, DPP-4 inhibitors, especially gemigliptin, substantially decreased albuminuria and renal fibrosis in mice with unilateral ureteral obstruction [5] and attenuated podocyte injury in mice with diabetic nephropathy [6].